SFX by Ex Libris Inc.

Title:	Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Source:	Nature [0028-0836] Fraietta, Joseph yr:2018

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ellebrecht, Christoph T. "Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease." Science 353.6295 (2016): 179-184.
description	2.	Wegmann, S. "Tau protein liquid–liquid phase separation can initiate tau aggregation." The EMBO journal. 37.7.
description	3.	Eyquem, J. "Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection." Nature 543.7643 (2017): 113-117.
description	4.	Mbitikon Kobo, F. "Ex vivo measurement of the cytotoxic capacity of human primary antigen-specific CD8 T cells." Journal of immunological methods 375.1-2 (2011): 252-257.
description	5.	Clemente Casares, X. "Expanding antigen-specific regulatory networks to treat autoimmunity." Nature 530.7591 (2016): 434-40.
description	6.	Swamy, M. "A Cholesterol-Based Allostery Model of T Cell Receptor Phosphorylation." Immunity 44.5 (2016): 1091-1101.
description	7.	Van Den Berge, M.. "Prevalence of human cell material: DNA and RNA profiling of public and private objects and after activity scenarios." Forensic science international. Genetics 21.C (2016): 81-89.
description	8.	June, Carl H. "Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia." The New England journal of medicine 365.8 (2011): 725-733.
description	9.	Gebel, Howard M M. "Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk." American journal of transplantation 3.12 (2004): 1488-500.
description	10.	Bai, Y. "Correction of a Genetic Disease in Mouse via Use of CRISPR-Cas9." Cell stem cell 13.6 (2013): 659-662.
description	11.	"Tau Aggregation." Neuroscience. 518: 64-69.
description	12.	Eftekharzadeh, B. "Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease." Neuron 99.5 (2018): 925-4294967295.
description	13.	Chen, C. "Chemical modifications of nucleic acid drugs and their delivery systems for gene‐based therapy." Medicinal research reviews 38.3: 829-869.
description	14.	Dubin, P. "Complex coacervation." Soft matter. 14.3: 329-330.
description	15.	Zhen, S. "In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9." Biochemical and biophysical research communications 450.4 (2014): 1422-1426.
description	16.	Sadelain, M. "The Basic Principles of Chimeric Antigen Receptor Design." Cancer discovery 3.4 (2013): 388-398.
description	17.	Pardoll, Drew M. "The blockade of immune checkpoints in cancer immunotherapy." Nature Reviews. Cancer 12.4 (2012): 252-264.
description	18.	Roder, A S C. "A new immunodeficiency disorder in humans involving NK cells." Nature 284.5756 (1980): 553-5.
description	19.	Rosenberg, Steven A. "A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response." Clinical cancer research 21.5 (2014): 1019-1027.
description	20.	Kalos, M. "T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia." Science translational medicine 3.95 (2011): 95-95.